Events | 2022.10.12
Biopharma Excellence Launches Groundbreaking ‘Science Huddle’ Series With First Panel Debate on Statistical Significance in a ‘Small Data’ World
The first panel discussion, on November 2nd, will tackle the theme Small data, big outcomes: strategies for achieving statistical significance when global patient populations are limited. Participants include the Deputy Director for Innovation Accelerator & Regulatory Science at MHRA; the CEO/Chair of Trustees at AKU Society; & the President/ CEO of Akari Therapeutics. They will discuss the scope of Bayesian statistics, predictive approaches, and pre-hoc analyses to overcome population challenges as biopharma becomes more narrowly targeted. Dr. Christian K. Schneider, Head of Biopharma Excellence at PharmaLex, and a world expert in adapting existing regulatory frameworks for biopharmaceuticals, will moderate the event.
(PRWeb October 12, 2022)
Read the full story at https://www.prweb.com/releases/2022/10/prweb18950443.htm
For more information, please visit
https://www.prweb.com/releases/2022/10/prweb18950443.htm
